Opioid Surveillance Webinar Series #1: Rapid surveillance of overdose morbidity - Developing case definitions, building queries, and analyzing results

This is the first of a series of three webinars presented for the ISDS Opioid Surveillance Webinar Series, June - July 2017.

This presentation describes how CDC has partnered with states to develop case definitions for all drug, opioid, and heroin within and outside of the NSSP/ESSENCE system. The presenters also share lessons learned and things to consider for the rapid surveillance of opioid overdose.

Presenters

June 15, 2017

Opioid Surveillance Webinar Series #2: Challenges and Implications of Postmarketing Surveillance of Prescription Opioids

The presentation will address the unique challenges of surveillance or prescription opioid abuse and present data from multiple perspectives on the issues and potential solution.

Presenter

Richard Dart, MD, PhD 
Director, Rocky Mountain Poison and Drug Center 
Executive Director, RADARS System 
Professor, University of Colorado Health Sciences Center 

June 29, 2017

A Second Chance: Overdose Prevention, Naloxone, and Human Rights in the United States

This report, published April 2017 from Human Rights Watch, explores measures required for an effective program to prevent opioid overdose deaths and current legal, policy and other challenges to be addressed.

January 02, 2018

Overdose Surveillance Committee (ODSC)

The mission of Overdose Surveillance Committee (ODSC) group is to organize and connect community members who are interested in overdose surveillance to discuss various issues concerning to this topic.

To learn more about the committee and participate in its activities, join the bimonthly calls scheduled for the first Friday every two months, from 1 - 2 pm ET. Look at the group calendar to find the next call!

 

November 30, 2018

Outbreak Report: Opioid-Related Overdose - Huntington, West Virginia, August 2016

This report, published January 27, 2017 by the Office of Epidemiology and Prevention Services with the West Virginia Department of Health & Human Resources, is an outbreak report developed in response to an opioid-related overdose incident that occured in Huntington, West Virginia on August 15, 2016.

May 24, 2017

Builiding Methods for a Proactive Prescription Drug Surveillance System

Prescription Drug Monitoring Programs (PDMPs) are operating in 49 states and several U.S. territories.

June 08, 2017

Going Beyond Chief Complaints to Identify Opioid-Related Emergency Department Visits

Overdoses of heroin and prescription opioids are a growing cause of mortality in the United States. Deaths from opioids have contributed to a rise in the overall mortality rate of middle-aged white males during an era when other demographics are experiencing life expectancy gains. A successful public health intervention to reverse this mortality trend requires a detailed understanding of which populations are most affected and where those populations live.

July 06, 2017

Characterizing Fentanyl-Associated Mortality using the Literal Causes of Death

In October 2015, the Centers for Disease Control and Prevention (CDC) released health advisory #384 to inform people about increases in fentanyl fatalities. Florida’s statewide syndromic surveillance system, Electronic Surveillance System for the Early Notification of Community-based Epidemics (ESSENCE-FL), captures electronic death record data in near real time which allows for the monitoring of mortality trends across the state.

August 15, 2017

Prescription Opioid Abuse: Gleaning insights from hospital and vital records data

There is a resurgence in the need to evaluate the economic burden of prescription drug hospitalizations in the United States. We used the Wisconsin 2014 Hospital Discharge data to examine opioid related hospitalization incidence and costs. Fentanyl, a powerful synthetic opioid, is frequently being used for as an intraoperative agent in anesthesia, and post-operative recovery in hospitals. According to a 2013 study, synthetic Fentanyl is 40 times more potent than heroin and other prescription opioids; the strength of Fentanyl leads to substantial hospitalizations risks.

March 14, 2017

Pages

Contact Us

INTERNATIONAL SOCIETY FOR
DISEASE SURVEILLANCE

288 Grove Street, Box 203
Braintree, MA 02184
(617) 779 0880
Email:syndromic@syndromic.org

This Knowledge Repository is made possible through the activities of the Centers for Disease Control and Prevention Cooperative Agreement/Grant #1 NU500E000098-01, National Surveillance Program Community of Practice (NSSP-CoP): Strengthening Health Surveillance Capabilities Nationwide, which is in the interest of public health.

Site created by Fusani Applications